Notable Labs Notable Labs
  • ABOUT
    • ABOUT US
    • OUR MISSION
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • PLATFORM & PIPELINE
    • PREDICTIVE PRECISION MEDICINE PLATFORM
    • VOLASERTIB & FOSCICLOPIROX
  • NEWS
    • All News
    • Investor Events and Presentations
    • Press Releases
    • Scientific Presentations & Publications
    • Content Search
  • Investors
    • Investor Overview
    • SEC Filings
    • Financials
    • Governance
    • IR Contacts
    • Partnership
    • Stock Information
  • Careers
  1. You are here:  
  2. Scientific Posters
  3. Successful Treatment with Bortezomib, Panobinostat, and Dexamethasone of Acute Myeloid Leukemia (AML) in 2nd Relapse After Allogeneic Stem Cell Transplantation (SCT): Therapy Selected Based Upon Results of a Personalized Flow Cytometric Screen for Drug
Details
Category: Scientific Presentations
11.Aug

Successful Treatment with Bortezomib, Panobinostat, and Dexamethasone of Acute Myeloid Leukemia (AML) in 2nd Relapse After Allogeneic Stem Cell Transplantation (SCT): Therapy Selected Based Upon Results of a Personalized Flow Cytometric Screen for Drug

Notable Labs uses a flow cytometric-based assay to test a panel of FDA-approved chemotherapy and targeted agents—singly and in combinations using a custom robotic platform—to determine anti-cancer effect against individual patient’s tumor cells.

Viewable PDF:

CLICK HERE

 

To learn more, share ideas, or join our mission.
Contact us today!

CONNECT WITH US

  • PRIVACY POLICY
  • TERM OF USE
  • COOKIE STATEMENT
  • INVESTOR OVERVIEW
  • CAREERS
  • CONTACT US

Copyright © 2023 Notable

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.

Accept Decline
Cookie Statement